Alain Merieux & family (#704)
- $ 6 B
- Pharmaceuticals
- France
- M
- 88 Years
Rest in Peace Ask Jeeves, every search comes to an end
County commissioners call on lawmakers to up funding for 911 dispatch systems
Spirit Airlines Is Going Out Of Business; Effective IMMEDIATELY
Pokémon Scalpers Selling Limited-Edition Pop-Tarts For Ridiculous Prices
Bennett says Netanyahu gov't 'boycotting' West Bank settlements amid Carrefour subsidy deal
Golf gear on sale now: Up to 65% off adidas, 45% off Puma, 15% off Mizuno, more
Families across the US can't find childcare — this map shows where it's worst
Median sales surge 61% in a Queens neighborhood that’s now the fifth priciest in NYC
Greg Brockman says his stake in OpenAI is worth nearly $30 billion
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
About Me
Alain Merieux is chairman of Institut Merieux, a medicine and public health conglomerate specializing in diagnostics, immunotherapy and nutrition. Alain's grandfather, Marcel Merieux, founded the institute in 1897. Alain founded BioMerieux, one of the firm's publicly traded arms, which specializes in diagnostic tests for infectious diseases such as tuberculosis. The firm's other publicly-traded subsidiary, Transgene, develops vaccines to combat infectious diseases and cancers. Alain's third son Alexandre, who shares the fortune, was named CEO of BioMerieux in 2014.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Alain Merieux & family’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Alain Merieux & family’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $5.9B
(May 4, 2026)
© Iconic Billionaires